SMN1 and proximal spinal muscular atrophy: Currently, three authorized treatments which are able to increase SMN protein levels are available for SMA patients, namely nusinersen (Spinraza), onasemnogene abeparvovec (Zolgensma), and risdiplam (Evrysdi).